Sarepta Therapeutics, Inc. — Director's Dealing 2020

Dec 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2020-12-08

Reporting Person: Bratica Joseph (Principal Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-08	Common Stock	M	1125	$29.60	Acquired	9265	Direct
2020-12-08	Common Stock	S	1125	$160.00	Disposed	8140	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-08	Stock Option (right to buy)	$29.60	M	1125	Disposed	2027-03-31	Common Stock (1125)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

F2: Amount of Securities Beneficially Owned includes 308 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2020.